摘要
Propofol (2,6-diisopropylphenol) is probably the most widely used intravenous anesthetic agent in daily practice. It has been reported to show immunomodulatory activity. However, the effect of propofol on the differention of T cells remains unclear. In this study, we demonstrated for the first time that propofol inhibited both interleukin (IL)-6 plus transforming growth factor-β (TGF-β)-induced Th17 cell differentiation in vitro and in LPS-challenged mice. Propofol also suppressed the IL-6-induced phosphorylation of Janus kinase-2 (JAK2)/signal transducer and activator of transcription (STAT3) pathway, a cytokine-activated essential transcription factor in Th17 cell development, which occurred concomitantly with the enhancement of suppressor of cytokine signaling-3 (SOCS3) expression involved in the downregulation of STAT3 phosphorylation. These data extend our knowledge of the immunosuppressive effects of propofol and their underlying mechanism.
| 原文 | 英語 |
|---|---|
| 頁(從 - 到) | 211-218 |
| 頁數 | 8 |
| 期刊 | Immunopharmacology and Immunotoxicology |
| 卷 | 39 |
| 發行號 | 4 |
| DOIs | |
| 出版品狀態 | 已出版 - 04 07 2017 |
| 對外發佈 | 是 |
文獻附註
Publisher Copyright:© 2017 Informa UK Limited, trading as Taylor & Francis Group.
指紋
深入研究「Inhibitory effects of propofol on Th17 cell differentiation」主題。共同形成了獨特的指紋。引用此
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver